Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT ID: NCT01349712
Last Updated: 2011-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2011-05-31
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
NCT01375725
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177
Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants
NCT03296982
Blood Donation From Warfarin Users for the Development of POC INR Monitor
NCT02355730
Venous Thromboembolism Taskforce Audit Program
NCT00535171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coumadin (warfarin)
Subjects are required to be currently receiving coumadin (warfarin) treatment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 years or older
* Able and willing to provide informed consent
* Can understand (read and write) English
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universal Biosensors Pty Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
College of Pharmacy Harding University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Ward, Pharm D
Role: PRINCIPAL_INVESTIGATOR
Harding University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
White River Diagnostic Clinic
Batesville, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MOB 0158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.